Ching‐Hon Pui

1.2k total citations
12 papers, 841 citations indexed

About

Ching‐Hon Pui is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ching‐Hon Pui has authored 12 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ching‐Hon Pui's work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Neutropenia and Cancer Infections (4 papers). Ching‐Hon Pui is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (7 papers) and Neutropenia and Cancer Infections (4 papers). Ching‐Hon Pui collaborates with scholars based in United States, Italy and El Salvador. Ching‐Hon Pui's co-authors include Michael L. Hancock, Jeffrey E. Rubnitz, James M. Boyett, Frederick G. Behm, Gaston K. Rivera, Susana C. Raimondi, Dario Campana, Elaine Coustan‐Smith, Joaquín Sánchez and J T Sandlund and has published in prestigious journals such as The Lancet, JAMA and Cancer.

In The Last Decade

Ching‐Hon Pui

12 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Hon Pui United States 9 607 446 345 157 154 12 841
M V Relling United States 9 605 1.0× 307 0.7× 325 0.9× 254 1.6× 176 1.1× 14 877
Bruce Camitta United States 8 482 0.8× 464 1.0× 210 0.6× 86 0.5× 114 0.7× 17 645
D Pei United States 7 530 0.9× 215 0.5× 430 1.2× 123 0.8× 113 0.7× 7 729
Ólafur Gísli Jónsson Iceland 15 543 0.9× 250 0.6× 427 1.2× 133 0.8× 167 1.1× 39 798
Myriam Campbell Chile 11 443 0.7× 287 0.6× 301 0.9× 64 0.4× 114 0.7× 21 580
G. Schellong Germany 11 448 0.7× 260 0.6× 277 0.8× 121 0.8× 96 0.6× 31 676
Ching-Hon Pui United States 10 397 0.7× 169 0.4× 285 0.8× 87 0.6× 96 0.6× 10 517
Maya Mahmoud United States 4 268 0.4× 248 0.6× 128 0.4× 161 1.0× 108 0.7× 7 546
G E van Zanen Netherlands 12 392 0.6× 167 0.4× 364 1.1× 64 0.4× 141 0.9× 20 673
J.D. Critchlow United Kingdom 10 428 0.7× 129 0.3× 112 0.3× 196 1.2× 266 1.7× 14 843

Countries citing papers authored by Ching‐Hon Pui

Since Specialization
Citations

This map shows the geographic impact of Ching‐Hon Pui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hon Pui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hon Pui more than expected).

Fields of papers citing papers by Ching‐Hon Pui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Hon Pui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hon Pui. The network helps show where Ching‐Hon Pui may publish in the future.

Co-authorship network of co-authors of Ching‐Hon Pui

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Hon Pui. A scholar is included among the top collaborators of Ching‐Hon Pui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Hon Pui. Ching‐Hon Pui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Inaba, Hiroto, Clinton F. Stewart, Kristine R. Crews, et al.. (2009). Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia. Cancer. 116(1). 98–105. 26 indexed citations
2.
3.
Razzouk, Bassem I., Elihu H. Estey, Stanley Pounds, et al.. (2006). Impact of age on outcome of pediatric acute myeloid leukemia. Cancer. 106(11). 2495–2502. 42 indexed citations
4.
Lowe, Eric, Ching‐Hon Pui, Michael L. Hancock, et al.. (2004). Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatric Blood & Cancer. 45(1). 10–15. 71 indexed citations
5.
Pui, Ching‐Hon, et al.. (2000). TOPOISOMERASE II INHIBITOR‐RELATED ACUTE MYELOID LEUKAEMIA. British Journal of Haematology. 109(1). 13–23. 133 indexed citations
6.
Evans, William E., Ching‐Hon Pui, & Mary V. Relling. (1999). Defining the Optimal Dosage of Methotrexate for Childhood Acute Lymphoblastic Leukemia. Advances in experimental medicine and biology. 457. 537–541. 4 indexed citations
7.
Coustan‐Smith, Elaine, Frederick G. Behm, Joaquín Sánchez, et al.. (1998). Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. The Lancet. 351(9102). 550–554. 329 indexed citations
8.
9.
Pui, Ching‐Hon. (1995). Outcome of Treatment for Childhood Cancer in Black as Compared With White Children. JAMA. 273(8). 633–633. 77 indexed citations
10.
Hurwitz, Craig A., et al.. (1993). Adverse prognostic features in 251 children treated for acute myeloid leukemia. Medical and Pediatric Oncology. 21(1). 1–7. 12 indexed citations
11.
Pui, Ching‐Hon, et al.. (1992). T-Cell Acute Lymphoblastic Leukemia with t(11;14) in Children. Leukemia & lymphoma. 7(5-6). 351–358. 3 indexed citations
12.
Furman, Wayne L., James Fontanesi, Omar Hustu, et al.. (1990). Testicular relapse in children with acute nonlymphoblastic leukemia. Cancer. 66(10). 2095–2098. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M V Relling Breakdown of academic impact, for papers by Bruce Camitta Breakdown of academic impact, for papers by D Pei Breakdown of academic impact, for papers by Ólafur Gísli Jónsson Breakdown of academic impact, for papers by Myriam Campbell Breakdown of academic impact, for papers by G. Schellong Breakdown of academic impact, for papers by Ching-Hon Pui Breakdown of academic impact, for papers by Maya Mahmoud Breakdown of academic impact, for papers by G E van Zanen Breakdown of academic impact, for papers by J.D. Critchlow
Rankless by CCL
2026